{"id":244959,"date":"2013-02-06T14:45:56","date_gmt":"2013-02-06T14:45:56","guid":{"rendered":"http:\/\/www.eugenesis.com\/bond-labs-nds-nutrition-launches-new-weight-loss-product\/"},"modified":"2013-02-06T14:45:56","modified_gmt":"2013-02-06T14:45:56","slug":"bond-labs-nds-nutrition-launches-new-weight-loss-product","status":"publish","type":"post","link":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nutrition\/bond-labs-nds-nutrition-launches-new-weight-loss-product.php","title":{"rendered":"Bond Labs&#039; NDS Nutrition Launches New Weight Loss Product"},"content":{"rendered":"<p><p>    OMAHA, Neb.--(BUSINESS WIRE)--  <\/p>\n<p>    Bond Laboratories, Inc. (OTCBB:BNLB)    (Bond Labs), an international provider of innovative and    proprietary nutritional supplements for health conscious    consumers marketed primarily through its wholly owned operating    division, NDS Nutrition Products (NDS), is pleased to    announce that the Company is introducing another new, cutting    edge product, EvoLean, to its impressive list of effective    diet and weight loss formulations.  <\/p>\n<p>    New product innovation is an integral part of our ongoing    growth strategy, stated Bond Laboratories, Inc. CEO, John S.    Wilson, and NDS has a long-standing tradition of developing    high-quality dietary and nutritional supplements. EvoLean,    which launches exclusively in GNC franchise locations this    week, is yet another example of our commitment to product    excellence. EvoLeans low-stimulant formula boosts metabolism    through a powerful blend of four key ingredients, which have    been profiled and highly-touted on television by respected    medical professionals. Scott Steil of Nutra Bridge, the    exclusive distributor of 7-Keto, one of EvoLeans key    ingredients added, We are thrilled to partner with NDS    Nutrition to provide a revolutionary and efficacious dietary    option to people that demand outstanding results in a low    stimulant formula and look forward to working with NDS to    deliver additional science-backed solutions in the future that    deliver superior results to customers.  <\/p>\n<p>    Our revenue growth is dependent on new product innovation and    retail outlet expansion and we believe that EvoLean will be a    strong enhancement to our already powerful line of sports    nutrition and weight loss products, available both domestically    and internationally, through the GNC franchise system. GNC    currently has 1,624 international franchise operations in 56    countries as well as 928 domestic franchise stores. As you can    imagine, we are thrilled to introduce another new, quality    product into the multi-billion dollar weight loss category,    concluded Mr. Wilson.  <\/p>\n<p>    About Bond Labs  <\/p>\n<p>    Bond Laboratories is a manufacturer of innovative nutritional    supplements. The Company produces and markets products through    its NDS Nutrition division. NDS currently markets 48 products    to over 900 GNC franchise locations domestically, and up to 10    products internationally to GNC franchise locations in six    countries. Bond Labs is headquartered in Omaha, Nebraska. For    more information, please visit     <a href=\"http:\/\/www.bond-labs.com\" rel=\"nofollow\">http:\/\/www.bond-labs.com<\/a>.  <\/p>\n<p>    Forward-Looking Statement  <\/p>\n<p>    Statements in this release that are forward looking involve    known and unknown risks and uncertainties, which may cause the    Companys actual results in future periods to be materially    different from any future performance that may be suggested in    this news release. Such factors may include, but are not    limited to: the ability to of the Company to continue to grow    revenue; the Companys ability to continue to achieve positive    cash flow given the Company's existing and anticipated    operating and other costs; and the outcome of the Companys    pending litigation with the U.S. Department of Labor and our    former President alleging violations of certain unlawful    employment practices in connection with his separation from the    Company. Many of these risks and uncertainties are    beyond the Company's control. Reference is made to the    discussion of risk factors detailed in The Companys filings    with the Securities and Exchange Commission, including its    reports on Form 10-K and 10-Q. Readers are cautioned not to    place undue reliance on these forward-looking statements, which    speak only as of the dates on which they are made.  <\/p>\n<\/p>\n<p><!-- Auto Generated --><\/p>\n<p>Read the original here:<br \/>\n<a target=\"_blank\" href=\"http:\/\/finance.yahoo.com\/news\/bond-labs-nds-nutrition-launches-150000710.html;_ylt=A2KJ3CSHbBJRREsAwl3_wgt.\" title=\"Bond Labs&#39; NDS Nutrition Launches New Weight Loss Product\">Bond Labs&#39; NDS Nutrition Launches New Weight Loss Product<\/a><\/p>\n","protected":false},"excerpt":{"rendered":"<p> OMAHA, Neb.--(BUSINESS WIRE)-- Bond Laboratories, Inc. (OTCBB:BNLB) (Bond Labs), an international provider of innovative and proprietary nutritional supplements for health conscious consumers marketed primarily through its wholly owned operating division, NDS Nutrition Products (NDS), is pleased to announce that the Company is introducing another new, cutting edge product, EvoLean, to its impressive list of effective diet and weight loss formulations. New product innovation is an integral part of our ongoing growth strategy, stated Bond Laboratories, Inc.  <a href=\"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/nutrition\/bond-labs-nds-nutrition-launches-new-weight-loss-product.php\">Continue reading <span class=\"meta-nav\">&rarr;<\/span><\/a><\/p>\n","protected":false},"author":57,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"limit_modified_date":"","last_modified_date":"","_lmt_disableupdate":"","_lmt_disable":"","footnotes":""},"categories":[577479],"tags":[],"class_list":["post-244959","post","type-post","status-publish","format-standard","hentry","category-nutrition"],"modified_by":null,"_links":{"self":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/244959"}],"collection":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/users\/57"}],"replies":[{"embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/comments?post=244959"}],"version-history":[{"count":0,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/posts\/244959\/revisions"}],"wp:attachment":[{"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/media?parent=244959"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/categories?post=244959"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.euvolution.com\/futurist-transhuman-news-blog\/wp-json\/wp\/v2\/tags?post=244959"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}